Drug intelligence / Profile preview

ZAPZYT Acne Wash Cleanser

Development stage: Unknown
Lead developer: Focus Consumer Healthcare
Modality: Small Molecules
Administration: Topical

Overview

ZAPZYT Acne Wash Cleanser is an over-the-counter (OTC) topical acne wash formulated with 2% salicylic acid, a beta-hydroxy acid (BHA) that penetrates deep into pores to exfoliate dead skin cells, remove excess oil, and clear acne blemishes, blackheads, and whiteheads. The formulation is oil-free, alcohol-free, and fragrance-free, and it is enriched with soothing botanical extracts such as aloe vera and chamomile to minimize skin irritation and redness. Originally developed by Waltman Pharmaceuticals and subsequently acquired by Focus Consumer Healthcare, this dermatologist-recommended cleanser is clinically proven safe and effective for sensitive skin.

Brand names: ZAPZYT Acne Wash Cleanser
Other names: salicylic acid 2%

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ZAPZYT Acne Wash Cleanser.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZAPZYT Acne Wash Cleanser.